Yuanyuan Chen
208 Huancheng East Road
Hangzhou, 310000, China
Hangzhou, 310000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Rifapentine dosing for drug-susceptible tuberculosis: stage 1 of a seamless phase 2/3 randomized clinical trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 22, 2026
QT interval prolongation and cardiotoxicity in shorter regimens for rifampicin-resistant tuberculosis.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 16, 2026
Clinical characteristics, antimicrobial susceptibility patterns, and treatment outcomes of nontuberculous mycobacterial diseases in eastern China: a retrospective cohort study (2019-2022).
Journal: Microbiology spectrum
Published: December 09, 2025
Intrathecal Isoniazid and Dexamethasone Therapy May Improve Outcomes in Patients With Tuberculous Meningitis: A 2-Center Retrospective Cohort Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 28, 2025
A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: August 14, 2025
Plasma and CSF pharmacokinetic characteristics of second-line anti-tuberculosis drugs in a patient with multidrug-resistant tuberculous meningitis.
Journal: BMC infectious diseases
Published: July 25, 2025
Asymmetry of safeguarding regional air and water nitrogen boundaries in China.
Journal: National science review
Published: May 13, 2025
A preliminary study on the clinical value of simultaneous amplification and testing for tuberculosis (SAT-TB) for early therapeutic monitoring in multidrug-resistant/rifampicin-resistant tuberculosis.
Journal: BMC infectious diseases
Published: April 20, 2025
Acquired resistance during short-course treatment for rifampicin-resistant tuberculosis.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: April 14, 2025
Current drug susceptibility testing in the Löwenstein-Jensen medium leads to underestimating of prothionamide resistance in multi-drug resistant Mycobacterium tuberculosis.
Journal: BMC microbiology
Published: April 04, 2025
A Short, All-oral Regimen for Pre-extensively Drug-resistant Tuberculosis: A Multicenter Open-label Single-arm Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 08, 2024
The clinical value of metagenomic next-generation sequencing in the diagnosis of pulmonary tuberculosis and the exploration of lung microbiota characteristics.
Journal: Scientific reports
Published: November 04, 2024
Last Updated: 09/26/2026